Patterns of resource utilization and cost for postmenopausal women with hormone-receptor–positive, human epidermal growth factor receptor-2–negative advanced breast cancer in Europe

Table 2 Evidence base for chart review

Country	Charts, n	Participating physicians, n	Gynecologists, %^a
France	105	21	—
Germany	79	21	48
The Netherlands	68	19	—
Belgium (Flemish region)	84	17	24
Sweden	63	16	—
TOTAL	399	94	15

ISSN: 1471-2407